21643-42-5

Basic information

• Product Name: ACRYLIC ACID TETRADECYL ESTER
• Synonyms: ACRYLIC ACID TETRADECYL ESTER;TETRADECYL ACRYLATE;2-Propenoic acid, n-tetradecyl ester;2-Propenoicacid,tetradecylester;Tetradecyl2-propenoate;Tetradecylacrylat;Myristyl acrylate;Tetradecyl Acrylate (stabilized with MEHQ)
• CAS NO: 21643-42-5
• Molecular Formula: C₁₇H₃₂O₂
• Molecular Weight: 268.43
• EINECS: 244-491-1
• Mol File: 21643-42-5.mol
• Article Data: 5

Chemical Properties

• Melting Point: 14 °C
• Boiling Point: 138 °C / 0.4mmHg
• Flash Point: 125.4 °C
• Appearance: /
• Density: 0.87
• Vapor Pressure: 9.29E-05mmHg at 25°C
• Refractive Index: 1.4450 to 1.4490
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Water Solubility: 2μg/L at 20℃
• CAS DataBase Reference: ACRYLIC ACID TETRADECYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: ACRYLIC ACID TETRADECYL ESTER(21643-42-5)
• EPA Substance Registry System: ACRYLIC ACID TETRADECYL ESTER(21643-42-5)

Safety Data

• Hazardous Substances Data: 21643-42-5(Hazardous Substances Data)

Usage

Flammability and Explosibility

Nonflammable

InChI:InChI=1/C17H32O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-19-17(18)4-2/h4H,2-3,5-16H2,1H3

Upstream product

• 112-72-1 1-Tetradecanol 
• 79-10-7 acrylic acid 
• 814-68-6 acryloyl chloride 

Relevant articles and documents

Stable liquid foams from a new polyfluorinated surfactant

Liquid foams exhibiting long-term stability are a key-challenge in material design. Based on this perspective, new pyridinium polyfluorinated surfactants were synthesized from simple building blocks enabling unusually stable liquid foams. While the batch-generated foams were used for qualitative foaming evaluation, microfluidics allowed a quantitative insight into the aging effects of monodisperse foams.

Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA

CRISPR/Cas is a revolutionary gene editing technology with wide-ranging utility. The safe, non-viral delivery of CRISPR/Cas components would greatly improve future therapeutic utility. We report the synthesis and development of zwitterionic amino lipids (ZALs) that are uniquely able to (co)deliver long RNAs including Cas9 mRNA and sgRNAs. ZAL nanoparticle (ZNP) delivery of low sgRNA doses (15 nm) reduces protein expression by >90 % in cells. In contrast to transient therapies (such as RNAi), we show that ZNP delivery of sgRNA enables permanent DNA editing with an indefinitely sustained 95 % decrease in protein expression. ZNP delivery of mRNA results in high protein expression at low doses in vitro (?1). Intravenous co-delivery of Cas9 mRNA and sgLoxP induced expression of floxed tdTomato in the liver, kidneys, and lungs of engineered mice. ZNPs provide a chemical guide for rational design of long RNA carriers, and represent a promising step towards improving the safety and utility of gene editing.

Cosmetic emulsions containing acrylamide copolymer

Water-in-oil emulsions wherein the emulsifier is a copolymer of 1 mol of acrylamide with 2 to 20 mols of at least one ethylenically unsaturated ester copolymerizable therewith selected from the group consisting of vinyl alkylcarboxylates, alkyl and cycloalkyl acrylates, and alkly and cycloalkyl methacrylates, wherein the alkyl and cycloalkyl groups contain 6 to 24 carbon atoms, and the continuous phase is a cosmetically acceptable oil, which can be prepared easily, safely and inexpensively. The emulsions are substantially odorless and are cosmetically acceptable for the care of the skin.